Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study

被引：0
|
作者：
Acar, Ibrahim Halil [1 ]
Atalay, Figen [2 ]
Demirsoy, Esra Terzi [3 ]
Can, Ferda [4 ]
Guven, Zeynep Tugba [5 ]
Cetiner, Mustafa [6 ]
Tombak, Anil [7 ]
Comert, Melda [8 ]
Guvenc, Birol [1 ]
机构：
[1] Cukurova Univ, Dept Hematol, Dept Internal Med, Fac Med, Adana, Turkiye
[2] Baskent Univ, Istanbul Hosp, Hematol Clin, Ankara, Turkiye
[3] SBU Kocaeli Derince Training & Res Hosp, Hematol Clin, Kocaeli, Turkiye
[4] Ankara City Hosp, Hematol Clin, Ankara, Turkiye
[5] Erciyes Univ, Dept Hematol, Dept Internal Med, Fac Med, Kayseri, Turkiye
[6] Acibadem Maslak Hosp, Hematol Clin, Istanbul, Turkiye
[7] Mersin Univ, Dept Hematol, Dept Internal Med, Fac Med, Mersin, Turkiye
[8] SBU Gulhane Training & Res Hosp, Hematol Clin, Istanbul, Turkiye
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
MDS; myelodysplastic syndrome; darbepoetin alfa;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MDS-143
引用
下载
收藏
页码：S354 / S354
页数：1
相关论文
共 50 条
  • [31] A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study)
    Kobayashi, Takashi
    Nannya, Yasuhito
    Ichikawa, Motoshi
    Oritani, Kenji
    Kanakura, Yuzuru
    Tomita, Akihiro
    Kiyoi, Hitoshi
    Kobune, Masayoshi
    Kato, Junji
    Kawabata, Hiroshi
    Shindo, Motohiro
    Torimoto, Yoshihiro
    Yonemura, Yuji
    Hanaoka, Nobuyoshi
    Nakakuma, Hideki
    Hasegawa, Daisuke
    Manabe, Atsushi
    Fujishima, Naohito
    Fujii, Nobuharu
    Tanimoto, Mitsune
    Morita, Yasuyoshi
    Matsuda, Akira
    Fujieda, Atsushi
    Katayama, Naoyuki
    Ohashi, Haruhiko
    Nagai, Hirokazu
    Terada, Yoshiki
    Hino, Masayuki
    Sato, Ken
    Obara, Naoshi
    Chiba, Shigeru
    Usuki, Kensuke
    Ohta, Masatsugu
    Imataki, Osamu
    Uemura, Makiko
    Takaku, Tomoiku
    Komatsu, Norio
    Kitanaka, Akira
    Shimoda, Kazuya
    Watanabe, Kenichiro
    Tohyama, Kaoru
    Takaori-Kondo, Akifumi
    Harigae, Hideo
    Arai, Shunya
    Miyazaki, Yasushi
    Ozawa, Keiya
    Kurokawa, Mineo
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (12) : 1324 - 1332
  • [32] An Integrated Analysis of Darbepoetin Alfa (DAR) in the Treatment of Anemia in Patients with Low- or Intermediate-1 (int-1) Risk Myelodysplastic Syndrome (MDS)
    Platzbecker, Uwe
    Symeonidis, Argiris
    Goede, Jeroen Simon
    Guerci-Bresler, Agnes
    Delforge, Michel
    Oliva, Esther Natalie
    Mayer, Jiri
    Badre, Sejal
    Mehta, Bhakti
    Brandao, Cisio De Oliveira
    BLOOD, 2017, 130
  • [33] Effectiveness of darbepoetin alfa 200 mcg every 2 weeks (Q2W) for the treatment of anemia in myelodysplastic syndrome (MDS).
    Patton, J
    Sullivan, T
    Mun, Y
    Wallace, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 559S - 559S
  • [34] Darbepoetin alfa for treating anemia in patients with low-risk myelodysplastic syndromes: Exploratory analysis of baseline predictors of response.
    Gabrilove, J.
    Paquette, R.
    Lyons, R.
    Mushtaq, C.
    Sekeres, M.
    Lam, H.
    Dreiling, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 356S - 356S
  • [35] A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes
    U Platzbecker
    A Symeonidis
    E N Oliva
    J S Goede
    M Delforge
    J Mayer
    B Slama
    S Badre
    E Gasal
    B Mehta
    J Franklin
    Leukemia, 2017, 31 : 1944 - 1950
  • [36] A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes
    Platzbecker, U.
    Symeonidis, A.
    Oliva, E. N.
    Goede, J. S.
    Delforge, M.
    Mayer, J.
    Slama, B.
    Badre, S.
    Gasal, E.
    Mehta, B.
    Franklin, J.
    LEUKEMIA, 2017, 31 (09) : 1944 - 1950
  • [37] Darbepoetin Alfa for the Treatment of Anemic Patients with Myelodysplastic Syndrome: A Belgian Single-Arm, Companion Trial to the Arcade Phase 3 Study
    Delforge, Michel
    Mazure, Dominiek
    Vande Broek, Isabelle
    Caers, Jo
    Badre, Sejal
    Mehta, Bhakti
    Brandao, Cisio De Oliveira
    BLOOD, 2017, 130
  • [38] Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure) Clinical and Prognostic Associations
    van der Meer, Peter
    Beverborg, Niels Grote
    Pfeffer, Marc A.
    Olson, Kurt
    Anand, Inder S.
    Westenbrink, B. Daan
    McMurray, John J. V.
    Swedberg, Karl
    Young, James B.
    Solomon, Scott D.
    van Veldhuisen, Dirk J.
    CIRCULATION-HEART FAILURE, 2018, 11 (02)
  • [39] THE MYELODYSPLASTIC SYNDROME - A RETROSPECTIVE STUDY ON 38 PATIENTS
    SCHRAPPEBACHER, M
    STEFFEN, HM
    MAIER, M
    BERNARDS, P
    HOEFFKEN, A
    FATKENHEUER, G
    MEDIZINISCHE KLINIK, 1990, 85 (09) : 511 - 516
  • [40] Screening Patients with Myelodysplastic Syndrome and Aplastic Anemia for Paroxysmal Nocturnal Hemoglobinuria Clones: A Retrospective Study
    Shih, Andrew
    Chin-Yee, Ian H.
    Hedley, Ben
    Keeney, Mike
    Wells, Richard A.
    Sutherland, D. Robert
    Hsia, Cyrus C.
    BLOOD, 2011, 118 (21) : 1465 - 1465
12345